AVXL Anavex Life Sciences Corp.

Fundamentals / CIK 0001314052 / USD

Anavex Life Sciences Corp. reported $120.1M in total assets and a net loss of $13.02M through September 30, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AVXL in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$44.86MFY 2016 Net Income: -$14.74M2016FY 2017 Net Income: -$13.46M2017FY 2018 Net Income: -$17.25M2018FY 2019 Net Income: -$26.29M2019FY 2020 Net Income: -$26.28M2020FY 2021 Net Income: -$37.91M2021FY 2022 Net Income: -$47.98M2022FY 2023 Net Income: -$47.51M2023FY 2024 Net Income: -$43.00M2024FY 2025 Net Income: -$46.38M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Research & Development $37.59M $41.84M $43.72M $37.92M $32.98M $25.23M $22.26M $13.34M $10.67M $7.25M
Selling, General & Admin $13.82M $11.04M $12.05M -- -- -- -- -- -- --
Total Operating Expenses $51.41M $52.88M $55.76M $50.99M $42.00M -$31.09M $29.11M $19.33M $15.68M $15.59M
Operating Income -$51.41M -$52.88M -$55.76M -$50.99M -$42.00M -$31.09M -$29.11M -$19.33M -$15.68M -$15.59M
EBITDA -- -- -- -- -- -- -- -- -- -$15.59M
Income Before Tax -$46.38M -$43.00M -$47.50M -$47.62M -$37.64M -$26.26M -$26.21M -$17.18M -$13.40M -$14.71M
Net Income -$46.38M -$43.00M -$47.51M -$47.98M -$37.91M -$26.28M -$26.29M -$17.25M -$13.46M -$14.74M
Basic EPS -$0.54 -$0.52 -$0.60 -$0.62 -$0.54 -$0.45 -$0.54 -$0.39 -$0.33 -$0.42
Diluted EPS -$0.54 -$0.52 -$0.60 -$0.62 -$0.54 -$0.45 -$0.54 -$0.39 -$0.33 -$0.42
Basic Shares Outstanding 85.3M 83.5M 79.8M 76.9M 69.8M 58.2M 48.9M 44.7M 40.8M 35.2M
Diluted Shares Outstanding 85.3M 83.5M 79.8M 76.9M 69.8M 58.2M 48.9M 44.7M 40.8M 35.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Research & Development -- $4.19M $4.66M $7.29M $9.96M $9.89M $10.45M $11.61M
Selling, General & Admin $2.03M $2.29M $2.13M $3.55M $4.50M $2.62M $3.15M --
Total Operating Expenses -$6.74M $6.48M $6.78M $10.84M $14.46M $12.51M $13.59M $14.27M
Operating Income $6.74M -$6.48M -$6.78M -$10.84M -$14.46M -$12.51M -$13.59M -$14.27M
Income Before Tax -- -- -- -- -- -- -- -$11.74M
Income Tax Expense $0 $0 $18K -- -- -- -- --
Net Income $7.82M -$5.34M -$5.68M -$9.83M -$13.24M -$11.20M -$12.11M -$11.62M
Basic EPS $0.08 -$0.06 -$0.06 -- -$0.16 -$0.13 -$0.14 --
Diluted EPS $0.08 -$0.06 -$0.06 -- -$0.16 -$0.13 -$0.14 --
Basic Shares Outstanding 92.70B 92.7M 89.0M -- 85.38B 85.1M 84.8M --
Diluted Shares Outstanding 92.90B 92.7M 89.0M -- 85.38B 85.1M 84.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Cash & Cash Equivalents $102.6M $132.2M $151.0M $149.2M $152.1M $29.25M $22.19M $22.93M $27.44M $9.19M
Cash & Short-Term Investments $102.6M $132.2M $151.0M $149.2M $152.1M $29.25M $22.19M $22.93M $27.44M $9.19M
Total Current Assets -- -- -- -- -- -- $25.33M $26.05M $27.79M $9.45M
Total Non-Current Assets -- -- -- -- -- -- $0 $154K $52K $52K
Total Assets $103.8M $135.6M $154.4M $152.7M $161.6M $34.54M $25.33M $26.21M $27.84M $9.50M
Accounts Payable $4.25M $9.63M $4.32M $3.83M $4.74M $3.99M $3.52M $2.96M -- --
Total Current Liabilities -- -- -- -- $10.80M $7.31M $5.04M $3.88M $3.58M $3.19M
Total Non-Current Liabilities -- -- -- -- $0 $0 $0 $0 $0 $0
Total Liabilities $8.95M $15.30M $12.53M $10.21M $10.80M $7.31M $5.04M $3.88M $3.58M $3.19M
Common Stock $87K $85K $82K $78K $76K $62K $53K $46K $43K $36K
Retained Earnings -$382.4M -$336.1M -$293.1M -$245.6M -$197.6M -$159.7M -$133.4M -$107.1M -$91.48M -$78.02M
Total Stockholders' Equity $94.87M $120.3M $141.9M $142.5M $150.8M $27.24M $20.29M $22.32M $25.88M $6.31M
Total Equity $94.87M $120.3M $141.9M $142.5M $150.8M $27.24M $20.29M $22.32M $25.88M $6.31M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $118.3M $127.4M $131.7M $102.6M $101.2M $115.8M $120.8M $132.2M
Cash & Short-Term Investments $118.3M $127.4M $131.7M $102.6M $101.2M $115.8M $120.8M $132.2M
Total Assets $120.1M $128.8M $133.0M $103.8M $102.4M $117.1M $124.0M $135.6M
Accounts Payable $3.66M $2.52M $2.64M $4.25M $6.74M $7.00M $4.57M $9.63M
Total Liabilities $7.69M $7.06M $6.37M $8.95M $11.47M $17.38M $13.13M $15.30M
Common Stock $93K $93K $93K $87K $85K $85K $85K $85K
Retained Earnings -$385.6M -$393.5M -$388.1M -$382.4M -$372.6M -$359.4M -$348.2M -$336.1M
Total Stockholders' Equity $112.4M $121.7M $126.6M $94.87M $90.96M $99.76M $110.9M $120.3M
Total Equity $112.4M $121.7M $126.6M $94.87M $90.96M $99.76M $110.9M $120.3M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Net Income -$46.38M -$43.00M -$47.51M -$47.98M -$37.91M -$26.28M -$26.29M -$17.25M -$13.46M -$14.74M
Depreciation & Amortization -- -- -- -- -- -- -- -- -- $1.3K
Stock-Based Compensation $11.55M $9.44M $16.37M $18.38M $8.23M $4.88M $6.43M $5.52M $4.14M $5.06M
Change in Receivables -- -- -- -- -- -- -- -$30K $54K -$2.5K
Change in Payables -$5.38M $5.30M $497K -$914K $751K $466K $684K $38K -- --
Operating Cash Flow -$39.04M -$30.81M -$27.79M -$24.24M -$30.38M -$21.29M -$18.53M -$12.58M -$9.02M -$9.24M
Common Stock Issued -- $11.28M $27.88M $20.98M $153.2M $28.75M $17.83M $8.17M $27.27M $3.17M
Financing Cash Flow $9.43M $11.97M $29.65M $21.29M $153.2M $28.35M $17.78M $8.07M $27.27M $3.13M
Net Change in Cash -$29.61M -$18.84M $1.87M -$2.95M $122.9M $7.06M -$745K -- -- --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income $7.82M -$5.34M -$5.68M -$9.83M -$13.24M -$11.20M -$12.11M -$11.62M
Stock-Based Compensation -$17.08M $314K $1.11M $3.72M $4.32M $1.45M $2.06M $2.01M
Change in Payables $1.14M -$119K -$1.61M -$2.49M $2.01M $167K -$5.06M $6.07M
Operating Cash Flow -$9.10M -$4.44M -$7.15M -$8.60M -$12.46M -$5.86M -$12.12M -$6.66M
Financing Cash Flow $0 $113K $36.32M $10.02M -$2.14M $852K $708K $89K
Net Change in Cash -$9.10M -$4.33M $29.17M $1.41M -$14.61M -$5.00M -$11.41M -$6.57M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Return on Equity (ROE) -48.9% -35.8% -33.5% -33.7% -25.1% -96.5% -129.6% -77.3% -52.0% -233.6%
Return on Assets (ROA) -44.7% -31.7% -30.8% -31.4% -23.5% -76.1% -103.8% -65.8% -48.4% -155.1%
Current Ratio -- -- -- -- -- -- 5.03x 6.71x 7.75x 2.96x
Quick Ratio -- -- -- -- 14.09x 4.00x 4.40x 5.90x 7.66x 2.88x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Return on Equity (ROE) -11.6% -28.0% -31.5% -48.9% -53.0% -47.3% -41.9% -35.8%
Return on Assets (ROA) -10.8% -26.5% -30.0% -44.7% -47.0% -40.2% -37.5% -31.7%
Source: SEC EDGAR CompanyFacts (CIK 0001314052) · from September 30, 2005 Data through June 30, 2026 · synced Nov 20, 2026, 05:49 UTC · Open in terminal